| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 300 | 150 | 150 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| 400 SH TEVA PHARMACEUTICALS | 2009-06 | P | 2013-11 | 15,024 | 12,483 | 2,541 |
| Identifier | Return Reference | Explanation |
|---|
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 250 shares of ATT INC | 6,650 | 8,840 |
| 500 shares of AMEREN CORP | 16,312 | 20,440 |
| 500 shares of CONOCOPHILLIPS | 26,910 | 42,865 |
| 500 shares of DTE ENERGY COMPANY | 17,875 | 38,935 |
| 400 shares of WELLS FARGO CO NEW | 11,483 | 21,024 |
| 200 shares of CHEVRON CORP | 22,242 | 26,110 |
| 500 shares of KINDER MORGAN INC | 16,735 | 18,130 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| KAYNE ANDERSON MLP | AT COST | 14,538 | 19,445 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| POSTAGE | 18 | 18 | ||
| INVESTMENT ADVISORY FEES | 1,399 | 1,399 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| MISCELLANEOUS INCOME | 132 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 990-PF INCOME TAX | 78 | 78 | ||
| ANNUAL REGISTRATION | 15 | 15 | ||
| FOREIGN TAX | 19 | 19 |